This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money ...

在其他最近的新闻中，Edgewise Therapeutics一直是几家分析师公司和公司发展的焦点。Piper Sandler重申了增持评级，目标价为51美元，强调了即将到来的里程碑，如预计在3月底前发布的28天EDG-7500肥厚型心肌病数据。Scotiabank启动了跑赢大盘评级和50美元的目标价，引用Edgewise的药物候选品在走向商业化时实现显著销售的潜力。摩根大通将Edgewise ...

Wanting to escape the harried here and now, I opened T.H. White’s “The Once and Future King” I’d first read in 1958 at seventeen. I settled in to recapture ...

America’s highly insulated bottom-line private capital is usually safe and well out of the danger zone. This time it’s ...

In a report released today, Laura Chico from Wedbush maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report), with a price ...

US media reaction to the visit of Taoiseach Micheál Martin to the White House was mostly one of relief that there was no ...

Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B. Check out the portfolio's top holdings and notable stake ...

European plans to use a St. Patrick’s Day visit to appeal to Trump on trade and Ukraine slammed into his persistent ...

The Chicago Bulls have a surplus of guards on their roster. But could they make room in their long-term plans for one more?

BOULDER, Colo., March 11, 2025--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the company will present data on ...

Edgewise Therapeutics' stock soars on positive Becker Muscular Dystrophy trial results. Learn why EWTX is a promising buy with derisked programs.

周一，Piper Sandler重申对Edgewise ...